A large 2025 study published in Blood Advances examined more than 540,000 patients with type 2 diabetes across 21 countries and found that those taking GLP-1 medications had about a 20 percent lower risk of venous blood clots compared to those taking a different class of diabetes drug
doi:10.3390/medicina60030357 Hellstrm PM, Nslund E, Edholm T, et al
These shoppers over-index for nutrient-dense protein products, such as protein bars, powders, and fortified cereals
Im in my mid-30s, Im a dad, I have a dad bod, and I got to be comfortable with that because Im never going to be back to where I was when I was 25 years old, said Gee
Weight and metabolic changes in studies have been observed over several months , particularly after reaching higher maintenance doses
The safety profile of dual agonists is similar to pure GLP-1 agonists, with the main difference being slightly higher rates of GI side effects